In this article, we review the use of microarray analysis in Parkinson's disease (PD).
Narayan, G. et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.
The results showed that low dose protons altered the expression of more than 10% of the proteins listed in the microarray analysis in various protein functional groups.
All 3 methods provided enough RNA, of sufficient quality, for gene-expression microarray analysis in colorectal carcinoma.
(JPEG 329 kb) Supplementary Fig. S2 Quantification of gene expression by mRNA-Seq and microarray analysis in roots under −P and ++P stresses after 1, 5, and 10 days.
Exposure to TiO2 NPs during pregnancy via subcutaneous injection can alter the expression of genes related to apoptosis, which were determined by DNA microarray analysis in the brain of mouse offsprings [65].
The microarray analysis in this study was performed essentially as outlined in [18].
A recent microarray analysis in Parkinson's disease also yielded excellent results after careful dissection of the substantia nigra [24].
Further, a recent in planta microarray analysis in our lab revealed expression trend differences between UW551 and GMI1000.
The correlation between diurnal genes and biological pathways was widely revealed by microarray analysis in different species.
Microarray analysis in knock-out animals should be carefully examined to avoid misinterpretation in the gene expression profile.
